A Review of Eptinezumab Use in Migraine.

Datta, Abhigyan; Maryala, Shashi; John, Rebecca

Datta, Abhigyan; Maryala, Shashi; John, Rebecca.

Afiliação

Datta A; Medicine, Maulana Azad Medical College, New Delhi, IND.
Maryala S; Neurology, Gandhi Hospital, Hyderabad, IND.
John R; Neurology, Kannur Medical College, Kannur, IND.

Cureus ; 13(9): e18032, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34540516

Palavras-chave

anti-cgrp monoclonal antibody; clinical pharmacology; efficacy of eptinezumab; eptinezumab; migraine disorder; review of clinical trials; safety of eptinezumab

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446121
https://dx.doi.org/10.7759/cureus.18032

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446121
https://dx.doi.org/10.7759/cureus.18032

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article